After having traded a total of 10,000 shares all year, YFRM exchanged hands over 12 million times today with a money flow of close to $2,000,000. The stock was up 161% from its only trade of the year at the end of January.
PITTSTON, ME, Feb 05, 2013 (MARKETWIRE via COMTEX) -- YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce that it has signed a definitive agreement to acquire the Integrative Stem Cell Institute (the ISCI). The ISCI is a pioneer in the field of cell-based regenerative medicine. Combining a world-class medical facility with a state-of-the-art laboratory, the ISCI provides investigational treatments to patients as part of clinical studies, while providing long-term follow up to advance these promising therapies. The acquisition of the ISCI provides the Company with an entree into stem cell research and treatment. With the advent of regenerative medicine, clinics such as the ISCI have taken the years of scientific research and started to apply them to treatment of patients.
Investor Contact: Atlanta Capital Partners, LLC David Kugelman (866) 692-6847 email@example.com